Canopus BioPharma, in collaboration with Swinburne University in Australia, has developed a unique anti-bacterial compound derived from the plant Eremophila longifolia (Emubush), for use in the prevention and elimination of cariogenesis, halitosis, gingivitis and periodontitis.
These ethanolic extracts of the traditional Aboriginal medicinal plant inhibit the bacterium Streptococcus mutans and Streptococcus sobrinus, two cariogenic pathogens known to cause dental caries (cariogenesis).
In all tests carried out, the Emubush extract was as effective as chlorhexidine and Listerine and superior to ethanol, ingredients of conventional mouthwashes. Further development involves the formulation of this extract in a mouth wash and other oral hygiene products.
Canopus currently has patents pending for the use of an extract derived from the plant Eremophila longifolia for the prevention and treatment of cariogenesis (dental caries), halitosis (bad breath), gingivitis and periodontitis (gum disease).